News, Publishing/Information Services

Insights on the Facial Injectables Global Market to 2027 – by Product Type, Application Type, Application, End-user and Region

DUBLIN, Oct. 19, 2022 /PRNewswire/ — The “Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to  ResearchAndMarkets.com’s offering.

Research and Markets Logo

The global facial injectables market size reached US$ 7.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12.2 Billion by 2027, exhibiting a CAGR of 9.44% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.



Facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.



As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth.

Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals.

Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.



Key Questions Answered in This Report

1. What is the global facial injectables market growth?

2. What are the global facial injectables market drivers?

3. What are the key industry trends in the global facial injectables market?

4. What is the impact of COVID-19 on the global facial injectables market?

5. What is the global facial injectables market breakup by product type?

6. What is the global facial injectables market breakup by application type?

7. What is the global voltage regulators market breakup by end user?

8. What are the major regions in the global facial injectables market?

9. Who are the key companies/players in the global facial injectables market?



Key Topics Covered:



1 Preface



2 Scope and Methodology



3 Executive Summary



4 Introduction

4.1 Overview

4.2 Key Industry Trends



5 Global Facial Injectables Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast



6 Market Breakup by Product Type

6.1 Collagen

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Hyaluronic Acid (HA)

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Botulinum Toxin Type A

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 Calcium Hydroxylapatite (CaHA)

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 Polymethylmethacrylate Beads (PMMA Microspheres)

6.5.1 Market Trends

6.5.2 Market Forecast

6.6 Poly-L-Lactic Acid (PLLA)

6.6.1 Market Trends

6.6.2 Market Forecast

6.7 Others

6.7.1 Market Trends

6.7.2 Market Forecast



7 Market Breakup by Application Type

7.1 Aesthetics

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Therapeutics

7.2.1 Market Trends

7.2.2 Market Forecast



8 Market Breakup by Application

8.1 Facial Line Correction

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Lip Augmentation

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Face Lift

8.3.1 Market Trends

8.3.2 Market Forecast

8.4 Acne Scar Treatment

8.4.1 Market Trends

8.4.2 Market Forecast

8.5 Others

8.5.1 Market Trends

8.5.2 Market Forecast



9 Market Breakup by End User

9.1 Hospitals

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 Dermatology Clinics

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Others

9.3.1 Market Trends

9.3.2 Market Forecast



10 Market Breakup by Region

11 SWOT Analysis



12 Value Chain Analysis



13 Porters Five Forces Analysis



14 Price Analysis



15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

15.3.1 Allergan Plc

15.3.1.1 Company Overview

15.3.1.2 Product Portfolio

15.3.1.3 Financials

15.3.1.4 SWOT Analysis

15.3.2 Anika Therapeutics Inc.

15.3.2.1 Company Overview

15.3.2.2 Product Portfolio

15.3.2.3 SWOT Analysis

15.3.3 Bloomage BioTechnology

15.3.3.1 Company Overview

15.3.3.2 Product Portfolio

15.3.4 Johnson & Johnson

15.3.4.1 Company Overview

15.3.4.2 Product Portfolio

15.3.4.3 Financials

15.3.4.4 SWOT Analysis

15.3.5 Galderma Pharma S.A.

15.3.5.1 Company Overview

15.3.5.2 Product Portfolio

15.3.5.3 SWOT Analysis

15.3.6 Integra LifeSciences

15.3.6.1 Company Overview

15.3.6.2 Product Portfolio

15.3.6.3 Financials

15.3.6.4 SWOT Analysis

15.3.7 Ipsen (Mayroy SA)

15.3.7.1 Company Overview

15.3.7.2 Product Portfolio

15.3.8 Medytox Inc.

15.3.8.1 Company Overview

15.3.8.2 Product Portfolio

15.3.8.3 Financials

15.3.9 Merz Holding GmbH & Co. KG

15.3.9.1 Company Overview

15.3.9.2 Product Portfolio

15.3.9.3 Financials

15.3.10 Prollenium Medical Technologies Inc.

15.3.10.1 Company Overview

15.3.10.2 Product Portfolio

15.3.11 Sanofi

15.3.11.1 Company Overview

15.3.11.2 Product Portfolio

15.3.11.3 Financials

15.3.11.4 SWOT Analysis

15.3.12 SciVision Biotech Inc.

15.3.12.1 Company Overview

15.3.12.2 Product Portfolio

15.3.12.3 Financials

15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)

15.3.13.1 Company Overview

15.3.13.2 Product Portfolio

15.3.14 Suneva Medical Inc.

15.3.14.1 Company Overview

15.3.14.2 Product Portfolio

15.3.15 Bausch Health Companies Inc.

15.3.15.1 Company Overview

15.3.15.2 Product Portfolio

15.3.15.3 Financials

15.3.15.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/nd61kh

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/insights-on-the-facial-injectables-global-market-to-2027—by-product-type-application-type-application-end-user-and-region-301653594.html

SOURCE Research and Markets

Previous ArticleNext Article